Welcome to Social Bookmarking Website

Description: Cohance Lifesciences offers integrated ADC CDMO services for innovator programmes from discovery through Phase 2b clinical supply. Our scope covers payload and linker synthesis, including camptothecin-based payload chemistry, HPAPI handling, and payload-linker scale-up. Bioconjugation is delivered in the US through our strategic partner NJ Bio in Princeton, New Jersey. Keeping payload, linker and conjugation work on one coordinated programme reduces hand-offs between vendors and simplifies tech transfer. We support analytical development and clinical-phase supply for ADC sponsors in the USA, UK and Europe. Explore our integrated ADC CDMO services at cohance.com and contact our scientific team to discuss your programme.

Category:

Tag:

Description: Cohance Lifesciences offers end-to-end small molecule API development services backed by 100+ dedicated R&D scientists and expertise across 20+ reaction classes including hydrogenation, cyanation, cryogenics, and stereoselective synthesis. From route scouting and process optimization to analytical development and regulatory documentation, Cohance powers drug pipelines from concept to clinic with speed and scientific precision. Their 25,000 sq. ft. Genome Valley R&D Center in Hyderabad houses state-of-the-art flow chemistry platforms, high-pressure reactors, and integrated process safety labs. With USFDA, EMA, and PMDA approved manufacturing sites, 200+ global DMF filings, and comprehensive support for IND, IMPD, and DMF submissions, Cohance ensures seamless transition from development to GMP manufacturing. Whether you need early-phase feasibility studies, scale-up readiness, or lifecycle services including impurity profiling and solvent recovery, Cohance delivers a compliant, cost-effective, and agile small molecule development partnership.

Category:

Tag: